| Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding AM Owsianka, JM Timms, AW Tarr, RJP Brown, TP Hickling, A Szwejk, ... Journal of virology 80 (17), 8695-8704, 2006 | 315 | 2006 |
| Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33 AW Tarr, AM Owsianka, JM Timms, PC McClure, RJP Brown, TP Hickling, ... Hepatology 43 (3), 592-601, 2006 | 214 | 2006 |
| Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells CC Colpitts, LM Schang, H Rachmawati, A Frentzen, S Pfaender, ... Gut 63 (7), 1137-1149, 2014 | 193 | 2014 |
| In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome D Todt, A Gisa, A Radonic, A Nitsche, P Behrendt, PV Suneetha, ... Gut 65 (10), 1733-1743, 2016 | 190 | 2016 |
| Clinical course of infection and viral tissue tropism of hepatitis C virus–like nonprimate hepaciviruses in horses S Pfaender, JMV Cavalleri, S Walter, J Doerrbecker, B Campana, ... Hepatology 61 (2), 447-459, 2015 | 148 | 2015 |
| Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis PJ Peters, WM Sullivan, MJ Duenas-Decamp, J Bhattacharya, ... Journal of virology 80 (13), 6324-6332, 2006 | 131 | 2006 |
| Natural reservoirs for homologs of hepatitis C virus S Pfaender, RJP Brown, T Pietschmann, E Steinmann Emerging microbes & infections 3 (1), 1-9, 2014 | 111 | 2014 |
| Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors PJ Peters, MJ Duenas-Decamp, WM Sullivan, R Brown, C Ankghuambom, ... Retrovirology 5, 1-17, 2008 | 103 | 2008 |
| Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33 AW Tarr, AM Owsianka, D Jayaraj, RJP Brown, TP Hickling, WL Irving, ... Journal of General Virology 88 (11), 2991-3001, 2007 | 100 | 2007 |
| An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission AW Tarr, P Lafaye, L Meredith, L Damier-Piolle, RA Urbanowicz, A Meola, ... Hepatology 58 (3), 932-939, 2013 | 85 | 2013 |
| Flunarizine prevents hepatitis C virus membrane fusion in a genotype‐dependent manner by targeting the potential fusion peptide within E1 PM Perin, S Haid, RJP Brown, J Doerrbecker, K Schulze, C Zeilinger, ... Hepatology 63 (1), 49-62, 2016 | 73 | 2016 |
| Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization AW Tarr, RA Urbanowicz, D Jayaraj, RJP Brown, JA McKeating, WL Irving, ... Journal of virology 86 (5), 2739-2749, 2012 | 73 | 2012 |
| Intercompartmental Recombination of HIV-1 Contributes to env Intrahost Diversity and Modulates Viral Tropism and Sensitivity to Entry Inhibitors RJP Brown, PJ Peters, C Caron, MP Gonzalez-Perez, L Stones, ... Journal of virology 85 (12), 6024-6037, 2011 | 72 | 2011 |
| Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not … AW Tarr, RA Urbanowicz, MR Hamed, A Albecka, CP McClure, ... Journal of virology 85 (9), 4246-4257, 2011 | 69 | 2011 |
| A diverse panel of hepatitis C virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance RA Urbanowicz, CP McClure, RJP Brown, T Tsoleridis, MAA Persson, ... Journal of virology 90 (7), 3288-3301, 2016 | 68 | 2016 |
| Hepatitis E virus (HEV) ORF2 antigen levels differentiate between acute and chronic HEV infection P Behrendt, B Bremer, D Todt, RJP Brown, A Heim, MP Manns, ... The Journal of infectious diseases 214 (3), 361-368, 2016 | 63 | 2016 |
| Hepatitis C virus T Pietschmann, RJP Brown Trends in microbiology 27 (4), 379-380, 2019 | 59 | 2019 |
| Mutagenic effects of ribavirin on hepatitis E virus—viral extinction versus selection of fitness-enhancing mutations D Todt, S Walter, RJP Brown, E Steinmann Viruses 8 (10), 283, 2016 | 57 | 2016 |
| Immune protection against reinfection with nonprimate hepacivirus S Pfaender, S Walter, E Grabski, D Todt, J Bruening, I Romero-Brey, ... Proceedings of the National Academy of Sciences 114 (12), E2430-E2439, 2017 | 56 | 2017 |
| Genetic diversity underlying the envelope glycoproteins of hepatitis C virus: structural and functional consequences and the implications for vaccine design AW Tarr, T Khera, K Hueging, J Sheldon, E Steinmann, T Pietschmann, ... Viruses 7 (7), 3995-4046, 2015 | 53 | 2015 |
